Schedule 13G ownership disclosure
ContraVir Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 21234W400
Event date: 2019-06-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 171,598
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-037772
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Jun 27, 2019
- Reporting period
- Jun 18, 2019
- Description
- Schedule 13G beneficial ownership